Disclosure Panels Details Page

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Panel - Disclosures as of 08/17/2022

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Date Completed
Zahraa AlHilli MD None None None None 06/26/2022
Banu Arun MD AbbVie, Inc.
AstraZeneca Pharmaceuticals LP
None None None 04/13/2022
Marian Birkeland PhD None None None None 07/25/2022
Saundra Buys MD None None None None 01/22/2022
Heather Cheng PhD,MD Astellas Pharma US, Inc.
Clovis Oncology
Color Health, Inc
Janssen Pharmaceutica Products, LP
Medivation, Inc.
Phosplatin Therapeutics
sanofi-aventis U.S.
None None UpToDate 03/23/2022
Jane Churpek MD,MS Department of Defense
NIH
MDS Foundation
RUNX1 Research Program
UpToDate,Inc MDS Foundation|RUNX1 Research Program 04/29/2022
Eileen Cucinotta None None None None 06/13/2022
Mary Daly PhD,MD,FACP None None None None 07/03/2022
Susan Darlow PhD None None None None 08/01/2022
Susan Domchek MD AstraZeneca Pharmaceuticals LP AstraZeneca Pharmaceuticals LP
GlaxoSmithKline
None None 04/26/2022
Mary Dwyer MS None None None None 06/20/2022
Ahmed Elkhanany MD None None None None 06/28/2022
Susan Friedman DVM None None None None 06/22/2022
Michael Goggins MD None None None None 06/27/2022
Kristina Gregory OCN,MSN,RN None None None None 08/15/2022
Andrea Hagemann MD None None None None 04/06/2022
Ashley Hendrix MD None None None None 12/15/2021
Mollie Hutton MS,CGC None None None None 03/09/2022
Beth Karlan MD None Clearity Foundation
Ovarian Cancer Research Alliance
Bluestar Genomics
Grail
MercyBio
Roche Laboratories, Inc.
None 05/31/2022
Seema Khan MD None Besins Healthcare Ireland Ltd. None None 05/16/2022
Catherine Klein MD None None None None 06/03/2022
Wendy Kohlmann MS,CGC None None None None 07/24/2022
Allison Kurian MD,MSc Ambry Genetics
Myriad Genetic Laboratories, Inc.
None None None 05/22/2022
Christine Laronga FACS,MD None None None Royalties for editorial work 07/09/2022
Julie Mak MSc,MS,CGC None None VSee VSee 06/26/2022
John Mansour MD None None None None 01/19/2022
Kara Maxwell PhD,MD None None None None 04/28/2022
Kevin McDonnell PhD,MD None None None None 07/26/2022
Carolyn Menendez MD None None None None 07/28/2022
Sofia Merajver PhD,MD None None None Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. 02/28/2022
Barbara Norquist MD None None None None 04/10/2022
Kenneth Offit MD AnaNeo Therapeutics None None None 04/06/2022
Tuya Pal MD None None None None 04/05/2022
Donna Powell CMD,DHSc,RT(T) None None None None 06/21/2022
Gwen Reiser MS,CGC None None None None 06/22/2022
Leigha Senter-Jamieson MS,CGC None None AstraZeneca Pharmaceuticals LP
GlaxoSmithKline
None 07/11/2022
Kristen Shannon MS,CGC None Expert Witness None None 05/08/2022
Rebecca Shatsky MD Biocept
CytomX Therapeutics
Genentech, Inc.
Oncosec
Oncternal Inc.
Phoenix Molecular Designs
None AstraZeneca Pharmaceuticals LP
Oncosec
Puma Biotechnology
None 02/23/2022
Kala Visvanathan MD,MHS Cepheid
Optra Health
None None None 04/05/2022
Jeanna Welborn MD None None None None 04/29/2022
Myra Wick PhD,MD None None None None 05/22/2022
Matthew Yurgelun MD Janssen Pharmaceutica Products, LP UpToDate None Facing Our Risk of Cancer Empowered (FORCE) advocacy group 04/29/2022